• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唐氏综合征患者脑脊液中淀粉样 β 肽和淀粉样前体样蛋白 1 肽水平的改变。

Altered cerebrospinal fluid levels of amyloid β and amyloid precursor-like protein 1 peptides in Down's syndrome.

机构信息

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden,

出版信息

Neuromolecular Med. 2014 Jun;16(2):510-6. doi: 10.1007/s12017-014-8302-1. Epub 2014 Apr 18.

DOI:10.1007/s12017-014-8302-1
PMID:24740518
Abstract

Down's syndrome (DS) patients develop early Alzheimer's disease pathology with abundant cortical amyloid plaques, likely due to overproduction of the amyloid precursor protein (APP), which subsequently leads to amyloid β (Aβ) aggregation. This is reflected in cerebrospinal fluid (CSF) levels of the 42-amino acid long Aβ peptide (Aβ1-42), which are increased in young DS patients and decreases with age. However, it is unclear whether DS also affects other aspects of Aβ metabolism, including production of shorter C- and N-terminal truncated Aβ peptides, and production of peptides from the amyloid precursor-like protein 1 (APLP1), which is related to APP, and cleaved by the same enzymatic processing machinery. APLP1-derived peptides may be surrogate markers for Aβ1-42 production in the brain. Here, we used hybrid immunoaffinity-mass spectrometry and enzyme-linked immunosorbent assays to monitor several Aβ and APLP1 peptides in CSF from DS patients (n = 12) and healthy controls (n = 20). CSF levels of Aβ1-42 and three endogenous peptides derived from APLP1 (APL1β25, APL1β27 and APL1β28) were decreased in DS compared with controls, while a specific Aβ peptide, Aβ1-28, was increased in a majority of the DS individuals. This study indicates that DS causes previously unknown specific alterations of APP and APLP1 metabolism.

摘要

唐氏综合征(DS)患者出现大量皮质淀粉样斑块,早期就会发展为阿尔茨海默病病理,这可能是由于淀粉样前体蛋白(APP)过度产生,随后导致淀粉样β(Aβ)聚集。这反映在脑脊液(CSF)中 42 个氨基酸长的 Aβ肽(Aβ1-42)的水平上,在年轻的 DS 患者中增加,并随着年龄的增长而降低。然而,目前尚不清楚 DS 是否还会影响 Aβ代谢的其他方面,包括产生较短的 C-和 N-末端截断的 Aβ肽,以及由淀粉样前体样蛋白 1(APLP1)产生的肽,APLP1 与 APP 相关,并通过相同的酶切加工机制进行切割。APLP1 衍生的肽可能是大脑中 Aβ1-42 产生的替代标志物。在这里,我们使用混合免疫亲和质谱法和酶联免疫吸附测定法来监测来自 DS 患者(n = 12)和健康对照组(n = 20)的 CSF 中的几种 Aβ 和 APLP1 肽。与对照组相比,DS 患者的 CSF 中 Aβ1-42 和源自 APLP1 的三种内源性肽(APL1β25、APL1β27 和 APL1β28)水平降低,而大多数 DS 个体中的特定 Aβ 肽 Aβ1-28 增加。这项研究表明,DS 导致 APP 和 APLP1 代谢的先前未知的特定改变。

相似文献

1
Altered cerebrospinal fluid levels of amyloid β and amyloid precursor-like protein 1 peptides in Down's syndrome.唐氏综合征患者脑脊液中淀粉样 β 肽和淀粉样前体样蛋白 1 肽水平的改变。
Neuromolecular Med. 2014 Jun;16(2):510-6. doi: 10.1007/s12017-014-8302-1. Epub 2014 Apr 18.
2
Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid.探索唐氏综合征脑脊液中的阿尔茨海默病分子病理学。
Neurodegener Dis. 2014;14(2):98-106. doi: 10.1159/000358800. Epub 2014 Jun 27.
3
Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.鉴定唐氏综合征和阿尔茨海默病患者脑中单体和可溶聚集态 Aβ。
Neurosci Lett. 2021 May 29;754:135894. doi: 10.1016/j.neulet.2021.135894. Epub 2021 Apr 10.
4
Amyloid mis-metabolism in idiopathic normal pressure hydrocephalus.特发性正常压力脑积水的淀粉样蛋白代谢异常
Fluids Barriers CNS. 2016 Jul 29;13(1):13. doi: 10.1186/s12987-016-0037-y.
5
The 28-amino acid form of an APLP1-derived Abeta-like peptide is a surrogate marker for Abeta42 production in the central nervous system.一种源自 APLP1 的 28 个氨基酸形式的 Abeta 样肽是中枢神经系统中 Abeta42 产生的替代标志物。
EMBO Mol Med. 2009 Jul;1(4):223-35. doi: 10.1002/emmm.200900026.
6
Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer's Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration.阿尔茨海默病中脑脊液淀粉样β肽的等压定量:C末端截断与神经退行性变的早期指标相关。
J Proteome Res. 2015 Nov 6;14(11):4834-43. doi: 10.1021/acs.jproteome.5b00668. Epub 2015 Oct 16.
7
APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment.APLP1作为γ-分泌酶调节剂治疗的脑脊液生物标志物。
Alzheimers Res Ther. 2015 Dec 22;7(1):77. doi: 10.1186/s13195-015-0160-z.
8
An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid.一种在线纳升液相色谱-电喷雾-傅里叶变换离子回旋共振质谱联用方法,用于全面表征人及猫脑脊髓液中淀粉样蛋白β和淀粉样前体蛋白的内源性片段。
J Mass Spectrom. 2012 May;47(5):591-603. doi: 10.1002/jms.2987.
9
Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.阿尔茨海默病和年轻唐氏综合征大脑中β淀粉样蛋白11-40/42肽沉积的特征:N端截短的β淀粉样蛋白物种在阿尔茨海默病发病机制中的意义。
Acta Neuropathol. 2006 Aug;112(2):163-74. doi: 10.1007/s00401-006-0077-5. Epub 2006 Jun 1.
10
Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta.同型半胱氨酸代谢与脑脊液中可溶性淀粉样前体蛋白及β淀粉样蛋白水平相关。
J Neurochem. 2016 Oct;139(2):324-332. doi: 10.1111/jnc.13766. Epub 2016 Sep 30.

引用本文的文献

1
Recalibrating the Why and Whom of Animal Models in Parkinson Disease: A Clinician's Perspective.重新校准帕金森病动物模型的研究目的及适用对象:临床医生视角
Brain Sci. 2024 Jan 31;14(2):151. doi: 10.3390/brainsci14020151.
2
High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations.高可溶性淀粉样蛋白β42 可预测携带阿尔茨海默病致病突变的淀粉样蛋白阳性个体的正常认知。
J Alzheimers Dis. 2022;90(1):333-348. doi: 10.3233/JAD-220808.
3
High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosis.

本文引用的文献

1
Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid.探索唐氏综合征脑脊液中的阿尔茨海默病分子病理学。
Neurodegener Dis. 2014;14(2):98-106. doi: 10.1159/000358800. Epub 2014 Jun 27.
2
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.早发性常染色体显性阿尔茨海默病基因携带者脑影像学和体液生物标志物分析:以早老素 1 E280A 家系为例的病例对照研究。
Lancet Neurol. 2012 Dec;11(12):1048-56. doi: 10.1016/S1474-4422(12)70228-4. Epub 2012 Nov 6.
3
Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease.
在患有脑淀粉样变性的个体中,高脑脊液淀粉样β蛋白42与正常认知相关。
EClinicalMedicine. 2021 Jun 28;38:100988. doi: 10.1016/j.eclinm.2021.100988. eCollection 2021 Aug.
4
Blood Biomarkers for Alzheimer's Disease in Down Syndrome.唐氏综合征中阿尔茨海默病的血液生物标志物
J Clin Med. 2021 Aug 17;10(16):3639. doi: 10.3390/jcm10163639.
5
The AT(N) framework for Alzheimer's disease in adults with Down syndrome.唐氏综合征成年患者阿尔茨海默病的AT(N)框架
Alzheimers Dement (Amst). 2020 Oct 27;12(1):e12062. doi: 10.1002/dad2.12062. eCollection 2020.
6
Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain.21 三体脑类器官中的患者特异性阿尔茨海默病样病理学揭示 BACE2 作为人类大脑中 AD 基因剂量敏感抑制剂。
Mol Psychiatry. 2021 Oct;26(10):5766-5788. doi: 10.1038/s41380-020-0806-5. Epub 2020 Jul 10.
7
Disentangling the Amyloid Pathways: A Mechanistic Approach to Etiology.解析淀粉样蛋白途径:病因学的机制性研究方法
Front Neurosci. 2020 Apr 21;14:256. doi: 10.3389/fnins.2020.00256. eCollection 2020.
8
Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease.了解淀粉样前体蛋白突变在阿尔茨海默病中的作用。
Mol Psychiatry. 2018 Jan;23(1):81-93. doi: 10.1038/mp.2017.218. Epub 2017 Nov 7.
9
Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome.唐氏综合征患者阿尔茨海默病的临床特征和生物标志物。
Free Radic Biol Med. 2018 Jan;114:3-9. doi: 10.1016/j.freeradbiomed.2017.08.024. Epub 2017 Sep 1.
10
A Review of Biomarkers for Alzheimer's Disease in Down Syndrome.唐氏综合征中阿尔茨海默病生物标志物的综述
Neurol Ther. 2017 Jul;6(Suppl 1):69-81. doi: 10.1007/s40120-017-0071-y. Epub 2017 Jul 21.
γ-分泌酶抑制剂阿伐加司他在轻度至中度阿尔茨海默病2期研究中的安全性和耐受性
Arch Neurol. 2012 Nov;69(11):1430-40. doi: 10.1001/archneurol.2012.2194.
4
BACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous system.BACE1 抑制会引起特定的脑脊液β-淀粉样蛋白模式,从而确定中枢神经系统中的药物作用。
PLoS One. 2012;7(2):e31084. doi: 10.1371/journal.pone.0031084. Epub 2012 Feb 6.
5
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics.阿尔茨海默病的淀粉样蛋白级联假说:治疗药物开发的评估。
Nat Rev Drug Discov. 2011 Aug 19;10(9):698-712. doi: 10.1038/nrd3505.
6
Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment.阿尔茨海默病中的新型 aβ 异构体——它们在诊断和治疗中的作用。
Curr Pharm Des. 2011;17(25):2594-602. doi: 10.2174/138161211797416039.
7
Aspects of beta-amyloid as a biomarker for Alzheimer's disease.β-淀粉样蛋白作为阿尔茨海默病生物标志物的相关方面。
Biomark Med. 2007 Jun;1(1):59-78. doi: 10.2217/17520363.1.1.59.
8
A novel Abeta isoform pattern in CSF reflects gamma-secretase inhibition in Alzheimer disease.脑脊液中新型 Abeta 同工型模式反映了阿尔茨海默病中 γ-分泌酶的抑制作用。
Alzheimers Res Ther. 2010 Mar 29;2(2):7. doi: 10.1186/alzrt30.
9
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.阿尔茨海默病的脑脊液和血浆生物标志物。
Nat Rev Neurol. 2010 Mar;6(3):131-44. doi: 10.1038/nrneurol.2010.4. Epub 2010 Feb 16.
10
Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease.散发性和 PSEN1 A431E 相关家族性阿尔茨海默病患者脑脊液中淀粉样β肽特征明显不同。
Mol Neurodegener. 2010 Jan 14;5:2. doi: 10.1186/1750-1326-5-2.